Marc Venet

1.0k total citations
16 papers, 872 citations indexed

About

Marc Venet is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, Marc Venet has authored 16 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Organic Chemistry. Recurrent topics in Marc Venet's work include Retinoids in leukemia and cellular processes (5 papers), Estrogen and related hormone effects (4 papers) and Cancer-related Molecular Pathways (3 papers). Marc Venet is often cited by papers focused on Retinoids in leukemia and cellular processes (5 papers), Estrogen and related hormone effects (4 papers) and Cancer-related Molecular Pathways (3 papers). Marc Venet collaborates with scholars based in United States, France and Belgium. Marc Venet's co-authors include Patrick Angibaud, Gérard Sanz, David W. End, Walter Wouters, Jacky Van Dun, Eddy Freyne, Philippe Müller, D End, Gregory G. Germino and G. Willemsens and has published in prestigious journals such as Journal of Medicinal Chemistry, Human Molecular Genetics and British Journal of Cancer.

In The Last Decade

Marc Venet

16 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Venet United States 14 469 353 277 73 66 16 872
C. Gaudon France 11 569 1.2× 348 1.0× 139 0.5× 94 1.3× 65 1.0× 12 793
Shubin Sheng United States 10 398 0.8× 601 1.7× 179 0.6× 48 0.7× 119 1.8× 11 992
Jacek Ostrowski United States 15 569 1.2× 256 0.7× 88 0.3× 127 1.7× 63 1.0× 24 838
Puranik Purushottamachar United States 18 669 1.4× 181 0.5× 165 0.6× 26 0.4× 145 2.2× 45 1.0k
Rosanna Tedesco United States 13 345 0.7× 534 1.5× 368 1.3× 46 0.6× 107 1.6× 15 1.1k
M. Rosenberger United States 9 650 1.4× 312 0.9× 171 0.6× 79 1.1× 34 0.5× 22 881
Carole Peluso‐Iltis France 12 454 1.0× 301 0.9× 69 0.2× 172 2.4× 52 0.8× 26 691
Zahra Parandoosh United States 13 479 1.0× 79 0.2× 165 0.6× 52 0.7× 97 1.5× 31 692
Michael Klaus Switzerland 11 428 0.9× 225 0.6× 88 0.3× 57 0.8× 61 0.9× 14 609
Gisele Nishiguchi United States 10 304 0.6× 441 1.2× 299 1.1× 42 0.6× 148 2.2× 19 941

Countries citing papers authored by Marc Venet

Since Specialization
Citations

This map shows the geographic impact of Marc Venet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Venet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Venet more than expected).

Fields of papers citing papers by Marc Venet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Venet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Venet. The network helps show where Marc Venet may publish in the future.

Co-authorship network of co-authors of Marc Venet

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Venet. A scholar is included among the top collaborators of Marc Venet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Venet. Marc Venet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Angibaud, Patrick, Laurence Mévellec, Christophe Meyer, et al.. (2007). Impact on farnesyltransferase inhibition of 4-chlorophenyl moiety replacement in the Zarnestra® series. European Journal of Medicinal Chemistry. 42(5). 702–714. 7 indexed citations
2.
Poncelet, Alain, Marc Venet, Ria Wouters, et al.. (2005). Synthesis, Structure−Activity Relationship, and Receptor Pharmacology of a New Series of Quinoline Derivatives Acting as Selective, Noncompetitive mGlu1 Antagonists. Journal of Medicinal Chemistry. 48(6). 2134–2153. 82 indexed citations
3.
Angibaud, Patrick, et al.. (2004). Synthesis Routes Towards the Farnesyl Protein Transferase Inhibitor ZARNESTRATM. European Journal of Organic Chemistry. 2004(3). 479–486. 110 indexed citations
4.
Angibaud, Patrick, Ashis Saha, David W. End, et al.. (2003). 4-Methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the Farnesyltransferase inhibitor ZARNESTRA ™. Bioorganic & Medicinal Chemistry Letters. 13(24). 4361–4364. 13 indexed citations
5.
Angibaud, Patrick, Ann Devine, David W. End, et al.. (2003). 5-Imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(9). 1543–1547. 27 indexed citations
6.
Angibaud, Patrick, David W. End, Eddy Freyne, et al.. (2003). Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(24). 4365–4369. 19 indexed citations
7.
Venet, Marc, David W. End, & Patrick Angibaud. (2003). Farnesyl Protein Transferase Inhibitor ZARNESTRA™ R115777 - History of a Discovery. Current Topics in Medicinal Chemistry. 3(10). 1095–1102. 58 indexed citations
8.
Ginckel, R. Van, Bieneke Janssen, Wim Floren, et al.. (2002). Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity. British Journal of Cancer. 86(4). 605–611. 75 indexed citations
9.
Stoppie, P., Μ. Borgers, Lieve Dillen, et al.. (2000). R115866 Inhibits All-trans-Retinoic Acid Metabolism and Exerts Retinoidal Effects in Rodents. Journal of Pharmacology and Experimental Therapeutics. 293(1). 304–312. 96 indexed citations
10.
Freyne, Eddy, Alfons H. M. Raeymaekers, Marc Venet, et al.. (1998). Synthesis of LIAZALTM, a retinoic acid metabolism blocking agent (ramba) with potential clinical applications in oncology and dermatology. Bioorganic & Medicinal Chemistry Letters. 8(3). 267–272. 17 indexed citations
11.
Burn, Timothy C., Timothy D. Connors, William R. Dackowski, et al.. (1995). Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. Human Molecular Genetics. 4(4). 575–582. 199 indexed citations
12.
Wouters, Walter, R. De Coster, Jacky Van Dun, et al.. (1990). Comparative effects of the aromatase inhibitor R76713 and of its enantiomers R83839 and R83842 on steroid biosynthesis in vitro and in vivo. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 1049–1054. 30 indexed citations
13.
Wouters, Walter, R. De Coster, Jacky Van Dun, et al.. (1989). R 76713, a new specific non-steroidal aromatase inhibitor. Journal of Steroid Biochemistry. 32(6). 781–788. 76 indexed citations
14.
Mazièré, B., C. Crouzel, Marc Venet, et al.. (1988). Synthesis, affinity and specificity of 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 15(4). 463–468. 28 indexed citations
15.
Crouzel, C., et al.. (1988). Labeling of a serotoninergic ligand with 18F : [18F] setoperone. Journal of Labelled Compounds and Radiopharmaceuticals. 25(4). 403–414. 33 indexed citations
16.
Venet, Marc, et al.. (1982). Transposition des oximies de la 2H-naptho [1,8-bc] pyrannone-3 et de la 2H-benzo [b] furannone-3. Tetrahedron Letters. 23(12). 1255–1256. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Gaudon Breakdown of academic impact, for papers by Shubin Sheng Breakdown of academic impact, for papers by Jacek Ostrowski Breakdown of academic impact, for papers by Puranik Purushottamachar Breakdown of academic impact, for papers by Rosanna Tedesco Breakdown of academic impact, for papers by M. Rosenberger Breakdown of academic impact, for papers by Carole Peluso‐Iltis Breakdown of academic impact, for papers by Zahra Parandoosh Breakdown of academic impact, for papers by Michael Klaus Breakdown of academic impact, for papers by Gisele Nishiguchi
Rankless by CCL
2026